Low Risk, High Risk: Adjuvant Therapy in Resected p16+ Oropharyngeal Cancer with ≥5 Positive Ipsilateral Lymph Nodes
- PMID: 35964623
- DOI: 10.1016/j.ijrobp.2022.04.018
Low Risk, High Risk: Adjuvant Therapy in Resected p16+ Oropharyngeal Cancer with ≥5 Positive Ipsilateral Lymph Nodes
Comment in
-
Multistation Radiation.Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):12. doi: 10.1016/j.ijrobp.2022.04.034. Int J Radiat Oncol Biol Phys. 2022. PMID: 35964624 No abstract available.
-
Chemotherapy Only For High-risk Features.Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):13. doi: 10.1016/j.ijrobp.2022.05.032. Int J Radiat Oncol Biol Phys. 2022. PMID: 35964626 No abstract available.
-
Whose Neck Is on the Line?Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):14. doi: 10.1016/j.ijrobp.2022.06.058. Int J Radiat Oncol Biol Phys. 2022. PMID: 35964627 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources